Skip to content

ClinuxMDL/CavityPlus

Folders and files

NameName
Last commit message
Last commit date

Latest commit

 

History

5 Commits
 
 

Repository files navigation

CavityPlus

CavityPlus: a web server for protein cavity detection with pharmacophore modelling, allosteric site identification and covalent ligand binding ability prediction (submitted in NAR web server issue)

Abstract

CavityPlus is a web server that offers protein cavity detection and various functional analyses. Using protein three-dimensional structural information as the input, CavityPlus applies CAVITY to detect potential binding sites on the surface of a given protein structure and rank them based on ligandability and druggability scores. These potential binding sites can be further analysed using three submodules, CavPharmer, CorrSite, and CovCys. CavPharmer uses a receptor-based pharmacophore modelling program, Pocket, to automatically extract pharmacophore features within cavities. CorrSite identifies potential allosteric ligand-binding sites based on motion correlation analyses between cavities. CovCys automatically detects druggable cysteine residues, which is especially useful to identify novel binding sites for designing covalent allosteric ligands. Overall, CavityPlus provides an integrated platform for analysing comprehensive properties of protein binding cavities. Such analyses are useful for many aspects of drug design and discovery, including target selection and identification, virtual screening, de novo drug design, and allosteric and covalent-binding drug design. The CavityPlus web server is freely available at http://repharma.pku.edu.cn/cavityplus or http://www.pkumdl.cn/cavityplus.

Contact

Associate Professor Jianfeng Pei (email: [email protected])

Contributors

Youjun Xu ([email protected]), Shiwei Wang ([email protected]), Qiwan Hu ([email protected]), Shuaishi Gao([email protected]), Xiaomin Ma ([email protected]), Weilin Zhang ([email protected]), Yihang Shen ([email protected]), Fangjin Chen ([email protected]), Luhua Lai ([email protected]), Jianfeng Pei ([email protected])